The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
Open accessAbstract
Many guidelines for hepatocellular carcinoma (HCC) have been published and updated globally. In contrast to other cancers, there is a range of treatment options for HCC involving several multidisciplinary care of the patient. Consequently, enormous heterogeneity in management trends has been observed. To support standard care for HCC, we systematically appraised 8 current guidelines for HCC around the world, including 3 guidelines from Asia, 2 from Europe, and 3 from the United States according to the selection criteria of credibility influence and multi-faceted. After a systematic appraisal, we found that these guidelines have both similarities and dissimilarities in terms of surveillance and treatment allocation recommendations due to regional differences in disease and other variables (diagnosis, staging systems) secondary to the lack of a solid, high level of evidence. In contrast to other tumors, the geographic differences in tumor biology (i.e., areas of increased hepatitis B prevalence) and available resources (organ availability for transplantation, medical technology, accessibility to treatment, health systems, and health resources) make it impractical to have an internationally universal guideline for all patients with HCC. Although Barcelona-Clinic Liver Cancer (BCLC) has long been dominant system for treatment-guiding staging of HCC, many Asia-pacific experts do not fully agree with its principle. The concepts of BCLC, for surgical resection or other locoregional therapy, are considered too conservative. Asian guidelines represent consensus about surgical resection and TACE indication for more advanced tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,026
SINGAL, A., VOLK, M. L., WALJEE, A., SALGIA, R., HIGGINS, P., ROGERS, M. A. M., & MARRERO, J. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04014.x · Cited by 819
Arii, S., Yamaoka, Y., Futagawa, S., Inoue, K., Kobayashi, K., Kojiro, M., Makuuchi, M., Nakamura, Y., Okita, K., & Yamada, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20456 · Cited by 725
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717
The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma
Llovet, J. M., Fuster, J., & Bruix, J. (2004) · Liver Transplantation · doi:10.1002/lt.20034 · Cited by 700
Sangiovanni, A., Del Ninno, E., Fasani, P., De Fazio, C., Ronchi, G., Romeo, R., Morabito, A., de Franchis, R., & Colombo, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.049 · Cited by 600
Liver Transplantation for Hepatocellular Carcinoma
Bismuth, H., Majno, P., & Adam, R. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007120 · Cited by 561
Mitchell, D. G., Bruix, J., Sherman, M., & Sirlin, C. B. (2015) · Hepatology · doi:10.1002/hep.27304 · Cited by 484
ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions
Marrero, J. A., Ahn, J., & Reddy, R. K. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.213 · Cited by 477
Barbara, L., Benzi, G., Gaiani, S., Fusconi, F., Zironi, G., Siringo, S., Rigamonti, A., Barbara, C., Grigioni, W., Mazziotti, A., et al. (1992) · Hepatology · doi:10.1002/hep.1840160122 · Cited by 431
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications
Sheu, J.-C., Sung, J.-L., Chen, D.-S., Yang, P.-M., Lai, M.-Y., Lee, C.-S., Hsu, H.-C., Chuang, C.-N., Yang, P.-C., Wang, T.-H., et al. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90324-5 · Cited by 427
Trinchet, J.-C., Chaffaut, C., Bourcier, V., Degos, F., Henrion, J., Fontaine, H., Roulot, D., Mallat, A., Hillaire, S., Cales, P., et al. (2010) · Hepatology · doi:10.1002/hep.24545 · Cited by 400
Ebara, M., Ohto, M., Shinagawa, T., Sugiura, N., Kimura, K., Matsutani, S., Morita, M., Saisho, H., Tsuchiya, Y., & Okuda, K. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90923-6 · Cited by 394
Kokudo, N., Hasegawa, K., Akahane, M., Igaki, H., Izumi, N., Ichida, T., Uemoto, S., Kaneko, S., Kawasaki, S., Ku, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12464 · Cited by 391
Verslype, C., Rosmorduc, O., & Rougier, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds225 · Cited by 365
Wald, C., Russo, M. W., Heimbach, J. K., Hussain, H. K., Pomfret, E. A., & Bruix, J. (2013) · Radiology · doi:10.1148/radiol.12121698 · Cited by 363
Significance of Resection Margin in Hepatectomy for Hepatocellular Carcinoma: A Critical Reappraisal
Poon, R. T.-P., Fan, S.-T., Ng, I. O.-L., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00014 · Cited by 357
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Di Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S. F., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.019 · Cited by 350
LOPEZ, P. M., VILLANUEVA, A., & LLOVET, J. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02932.x · Cited by 344
Luo, J., Guo, R.-P., Lai, E. C. H., Zhang, Y.-J., Lau, W. Y., Chen, M.-S., & Shi, M. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1321-8 · Cited by 328
Trevisani, F. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04119-3 · Cited by 313
Santi, V., Trevisani, F., Gramenzi, A., Grignaschi, A., Mirici-Cappa, F., Poggio, P. D., Nolfo, M. A. D., Benvegnù, L., Farinati, F., Zoli, M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.010 · Cited by 304
Schwartz, J. D., Schwartz, M., Mandeli, J., & Sung, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00873-2 · Cited by 254
Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
Villanueva, A., Minguez, B., Forner, A., Reig, M., & Llovet, J. M. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.080608.100623 · Cited by 254
Fong, Z. V., & Tanabe, K. K. (2014) · Cancer · doi:10.1002/cncr.28730 · Cited by 250
Andersson, K. L., Salomon, J. A., Goldie, S. J., & Chung, R. T. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.005 · Cited by 242
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Study Group, K. L. C., & Korea(NCC), N. C. C. (2015) · Gut and Liver · doi:10.5009/gnl14460 · Cited by 230
Lee, H., Kim, J. S., Choi, I. J., Chung, J. W., Park, J. H., & Kim, C. Y. (1997) · PubMed · Cited by 221
Combined α fetoprotein testing and ultrasonography as a screening test for primary liver cancer
Zhang, B., & Yang, B. (1999) · Journal of Medical Screening · doi:10.1136/jms.6.2.108 · Cited by 162
Lencioni, R. A., Chen, X., Dagher, L., & Venook, A. P. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-42 · Cited by 153
Kim, C. K., Lim, J. H., & Lee, W. J. (2001) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2001.20.2.99 · Cited by 147
Ueno, S., Tanabe, G., Nuruki, K., Hamanoue, M., Komorizono, Y., Oketani, M., Hokotate, H., Inoue, H., Baba, Y., Imamura, Y., et al. (2002) · Hepatology Research · doi:10.1016/s1386-6346(02)00144-4 · Cited by 144
Staging systems of hepatocellular carcinoma: A review of literature
Maida, M. F., Orlando, E., Cammà, C., & Cabibbo, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i15.4141 · Cited by 138
Santagostino, E., Colombo, M., Rivi, M., Rumi, M. G., Rocino, A., Linari, S., & Mannucci, P. M. (2003) · Blood · doi:10.1182/blood-2002-10-3310 · Cited by 120
Han, K., Kudo, M., Ye, S.-L., Choi, J. Y., Poon, R. T.-P., Seong, J., Park, J., Ichida, T., Chung, J. W., Chow, P. K. H., et al. (2011) · Oncology · doi:10.1159/000333280 · Cited by 118
Song, P., Tobe, R. G., Inagaki, Y., Kokudo, N., Hasegawa, K., Sugawara, Y., & Tang, W. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02792.x · Cited by 117
Multimodal treatment of hepatocellular carcinoma
Graf, D., Vallböhmer, D., Knoefel, W. T., Kröpil, P., Antoch, G., Sagir, A., & Häussinger, D. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.03.001 · Cited by 97
Lee, J. M., Park, J., & Choi, B. I. (2014) · Digestive Diseases · doi:10.1159/000368020 · Cited by 72
Lin, C., Kee, K., Wang, J., Lee, C., Chen, C., Changchien, C., Hu, T., Cheng, Y., Hsu, H., Wang, C., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01702.x · Cited by 68
Schmidt, S., Follmann, M., Malek, N. P., Manns, M. P., & Greten, T. F. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06891.x · Cited by 37
ESMO clinical recommendations: a practical guide for medical oncologists
Pavlidis, N. A., Hansen, H., & Stahel, R. A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm362 · Cited by 13
Cited by
Progress in 3D bioprinting technology for tissue/organ regenerative engineering
Matai, I., Kaur, G., Seyedsalehi, A., McClinton, A., & Laurencin, C. T. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119536 · Cited by 1,156
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Yau, T., Hsu, C., Kim, T.-Y., Choo, S.-P., Kang, Y.-K., Hou, M.-M., Numata, K., Yeo, W., Chopra, A., Ikeda, M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.014 · Cited by 267
Yoon, J. S., Lee, H. A., Park, J. Y., Kim, B. H., Lee, I. J., Chon, Y. E., Hong, S. K., Lee, D. H., Kong, H.-J., Won, Y.-J., et al. (2020) · Journal of Liver Cancer · doi:10.17998/jlc.20.1.41 · Cited by 19
Metadata
- Authors
- Yu, S. J.
- Venue
- Clinical and Molecular Hepatology
- Published
- 2016-03-28
- Volume
- 22
- Issue
- 1
- Pages
- 7-17
- ISSN
- 2287-2728 (ISSN-L)
- 2287-285X
- OpenAlex
- W2319133637
- Cited by
- 273
- References
- 55
- FWCI
- 30.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.